1月16日，港股集体高开，其中恒生指数涨0.64%，报27094.85点，恒生科技指数涨0.94%，报5883.37 点，国企指数涨0.68%，报9330.22点，红筹指数涨0.08%，报4156.98点。 盘面上，大型科技股多数走高，阿里巴巴涨2%，腾讯控股涨0.8%，京东集团跌0.52%，小米集团涨 0.37%，美团涨1.09%，快手涨1.63%，哔哩哔哩涨1.02%；有色金属概念股普涨，万国黄金集团涨4%、 洛阳钼业涨2.68%、江西铜业股份涨2.17%；汽车股高开，比亚迪涨超1%；创新药概念多数上涨，巨子 生物涨超3%；中资券商股普涨，中州证券涨超2%。 企业新闻 中国南方航空股份(01055.HK)：2025年12月，客运运力投入同比上升11.89%，旅客周转量同比上升 11.20%，客座率为84.05%，同比下降0.53个百分点。货运运力同比上升19.28%，同比上升10.86%。 中国中冶(01618.HK)：2025年累计新签合同额人民币11,136.0亿元，同比降低10.8%。其中新签海外合同 额人民币948.8亿元，同比增长1.9%。 众安在线(06060.HK)：2025年度原保险保费收 ...

Summary of Key Points Core Viewpoint - On January 15, 42 Hong Kong-listed companies conducted share buybacks, totaling 28.45 million shares and an aggregate amount of HKD 945 million [1]. Group 1: Major Companies Involved - Tencent Holdings repurchased 1.017 million shares for HKD 636 million, with a highest price of HKD 632.00 and a lowest price of HKD 619.00, bringing its total buyback amount for the year to HKD 6.358 billion [1][2]. - Xiaomi Group-W bought back 3.90 million shares for HKD 148 million, with a highest price of HKD 37.92 and a lowest price of HKD 37.86, totaling HKD 1.241 billion in buybacks for the year [1][2]. - Sunny Optical Technology repurchased 1.20 million shares for HKD 79.01 million, with a highest price of HKD 66.45 and a lowest price of HKD 65.25, accumulating HKD 382.43 million in buybacks this year [1][2]. Group 2: Buyback Amounts and Quantities - The highest buyback amount on January 15 was from Tencent Holdings at HKD 636 million, followed by Xiaomi Group-W at HKD 148 million [1]. - In terms of share quantity, the largest buyback was by First Capital Holdings with 4.95 million shares, followed by Xiaomi Group-W with 3.90 million shares and Maple Leaf Education with 2.90 million shares [1][2]. Group 3: Additional Companies and Data - Other notable companies involved in buybacks include Giant Bio, AAC Technologies, and others, with varying amounts and share quantities [1][2][3]. - The buyback activity reflects a strategic move by these companies to enhance shareholder value amidst market conditions [1].

热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 美股周四表现向上，科技股业绩强劲，人工智能概念受到支持，带动大市反弹，三大指数均录得升幅收 市。美元走势向好，美国十年期债息回升至4.17厘水平，金价反复偏软，油价走势回落。 客户端 美股周四表现向上，科技股业绩强劲，人工智能概念受到支持，带动大市反弹，三大指数均录得升幅收 市。美元走势向好，美国十年期债息回升至4.17厘水平，金价反复偏软，油价走势回落。 今日港股三大指数集体高开，恒指开盘涨0.64%，报27094.85点，恒科指涨0.94%，国企指数涨0.68%。 盘面上，科网股涨跌不一，阿里巴巴涨2%，快手、美团、哔哩哔哩涨超1%，京东跌超0.5%；汽车股高 开，比亚迪涨超1%；创新药概念多数上涨，巨子生物涨超3%；有色金属板块回暖，紫金矿业涨超2%； 中资券商股普涨，中州证券涨超2%。 | 名称 | 最新价 | 涨跌幅 √ | | --- | --- | --- | | 恒生科技指数 | 5883.37 | +0.94% | | 800700 | | | | 国企指数 | 9330.22 | +0.68% | | 800100 | | | | ...

Major Events - Giant Bio (02367) received the Medical Device Registration Certificate from the National Medical Products Administration for its recombinant type I α1 collagen and sodium hyaluronate composite solution [1] - Jitu Express-W (01519) plans to subscribe for 226 million H shares of SF Holding and issue 822 million Class B shares to SF Holding [1] - Zijin Mining (02899) signed a cooperation and equity transfer agreement for the Shapingou Molybdenum Mine project [1] - Jiangxi Copper (00358) subsidiary signed an Investment Option Agreement with First Quantum for exploration cooperation in Kazakhstan's mining projects [1] - Derin Holdings (01709) received conditional approval from the CSRC for Derin Securities to provide virtual asset consulting services [1] - GAC Group (02238) subsidiary GAC Trumpchi received 100 million yuan in funding for industrial transformation and development [1] - Juteng International (03336) suspected of a cyber attack and has initiated a comprehensive investigation [1] Operating Performance - China Southern Airlines (01055) increased passenger capacity input by 11.89% year-on-year in December [1] - Air China (00753) reported a 10% year-on-year increase in passenger turnover in December [1] - China Eastern Airlines (00670) saw a 7.61% year-on-year increase in passenger turnover in December [1] - China Metallurgical Group (01618) new contract amount for 2025 is 1,113.6 billion yuan, a decrease of 10.8% year-on-year [1] - ZhongAn Online (06060) projected total original insurance premium income of approximately 35.643 billion yuan for 2025, an increase of 6.66% year-on-year [1] - China General Nuclear Power Corporation (01164) produced a total of 702.5 tons of natural uranium in the fourth quarter [1] - Jiuxing Holdings (01836) reported a 0.8% year-on-year increase in comprehensive income to 388.6 million USD in the fourth quarter [1] - Luoyang Molybdenum (03993) issued a profit warning, expecting annual net profit attributable to shareholders to be between 20 billion and 20.8 billion yuan, an increase of 47.80% to 53.71% year-on-year [1] - Chongqing Iron and Steel (01053) issued a profit warning, expecting a net loss of 2.5 billion to 2.8 billion yuan for 2025 [1] - Huiju Technology (01729) issued a profit warning, expecting annual net profit to increase by approximately 60% to 70% year-on-year [1]

| 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2026.01.15 | 40.00 | 36.100 | 35.440 | 1434.67 | | 2026.01.14 | 40.00 | 35.800 | 35.100 | 1415.00 | | 2026.01.13 | 40.00 | 36.200 | 35.640 | 1433.78 | | 2026.01.12 | 40.00 | 35.500 | 34.500 | 1400.29 | | 2026.01.09 | 40.00 | 34.580 | 34.240 | 1375.96 | | 2026.01.08 | 40.00 | 34.440 | 34.120 | 1371.06 | | 2026.01.07 | 40.00 | 34.680 | 34.300 | 1378.34 | | 2026.01.06 | 40.00 | 34.480 | 33.840 | 1366.93 | | 2026.01.05 | 40. ...

Core Viewpoint - The company, Juzi Biotechnology, announced that its wholly-owned subsidiary, Shaanxi Juzi Biotechnology Co., Ltd., has received a medical device registration certificate from the National Medical Products Administration of China for a recombinant type I α1 collagen and sodium hyaluronate composite solution product [1] Group 1 - The product is primarily composed of recombinant collagen and sodium hyaluronate [1] - It is intended for injection into the dermis to improve the smoothness of the cheek area [1]

巨子生物(02367)公布，2026年1月15日耗资约1434.67万港元回购40万股股份。 ...

智通财经APP讯，巨子生物(02367)公布，2026年1月15日耗资约1434.67万港元回购40万股股份。 ...

格隆汇1月15日丨巨子生物(02367.HK)发布公告，2026年1月15日耗资1434.7万港元回购40万股，回购价 格每股35.44-36.1港元。 ...

表格類別： 股票 狀態： 新提交 公司名稱： 巨子生物控股有限公司 呈交日期： 2026年1月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | ...